Nasal administration of mesenchymal stem cells restores cisplatin-induced cognitive impairment and brain damage in mice

Cognitive impairments are a common side effect of chemotherapy that often persists long after treatment completion. There are no FDA-approved interventions to treat these cognitive deficits also called ‘chemobrain’. We hypothesized that nasal administration of mesenchymal stem cells (MSC) reverses c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Gabriel S., Boukelmoune, Nabila, Chiang, Angie C.A., Peng, Bo, Rao, Vikram, Kingsley, Charles, Liu, Ho-Ling, Kavelaars, Annemieke, Kesler, Shelli R., Heijnen, Cobi J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238972/
https://www.ncbi.nlm.nih.gov/pubmed/30473752
http://dx.doi.org/10.18632/oncotarget.26272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238972/
https://www.ncbi.nlm.nih.gov/pubmed/30473752
http://dx.doi.org/10.18632/oncotarget.26272

Ejemplares similares